483 Intas Pharmaceuticals Dec 2018

483 Intas Pharmaceuticals Dec 2018

Vilmary Negron Rodriguez FDA$119.00 - Available Now

FDA investigators audited the Intas Pharmaceuticals - Ahmedabad, India facility and issued inspectional observations (via FDA 483) on 14 Dec 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 14 Dec 2018
  • Location: Ahmedabad, India
  • FEI: 3003157498
Add To Cart